ÂÜÀòÂÒÂ×

Kirsten Kester is a seasoned executive with extensive experience in business development and strategy within the life sciences sector. Currently serving as Senior Vice President of Business Development at Obsidian Therapeutics, Kirsten is a key member of the Executive Leadership Team focused on developing next-generation cell and gene therapies. Previous roles include Vice President of Business Development at Nashoba Brooks School and Senior Director of Life Sciences Strategy at Huron, where responsibilities included corporate strategy and alliance management across various therapeutic areas. Kirsten has held consulting positions with firms such as The Frankel Group and Sample6 Technologies, alongside experience in healthcare investment banking at Goldman Sachs. Educational qualifications include an MBA from Harvard Business School and a BA in Biology from Harvard University.